Terug
Dagbereik
€ 29,44
€ 31,32
52-Weeksbereik
€ 13,30
€ 31,76
Volume
1.010.285
50D / 200D Gem.
€ 27,54
/
€ 21,92
Vorige Slotkoers
€ 30,81
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -18,0 | 0,3 |
| P/B | 4,1 | 2,9 |
| ROE % | -27,0 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 43,33
+39.1%
Low: € 39,00
High: € 52,00
Forward WPA
-€ 2,12
Omzet Sch.
10000
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 1,90
-€ 1,90 – -€ 1,90
|
210 M | 1 |
| FY2029 |
-€ 3,47
-€ 3,47 – -€ 3,47
|
41 M | 1 |
| FY2028 |
-€ 3,81
-€ 5,11 – -€ 1,93
|
25000 | 5 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -70,46M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-26,95%
ROIC-19,51%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio28,66
Interest Coverage0,00
Waardering
P/E Ratio
-17,96
P/B Ratio4,05
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -103,69M |
| ROE | -26,95% | ROA | -21,78% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -70,46M |
| ROIC | -19,51% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 28,66 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -17,96 | P/B Ratio | 4,05 |
| P/S Ratio | N/A | PEG Ratio | 2,65 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,86B | Enterprise Value | 1,76B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -103,69M | -89,02M | -71,58M | -37,66M | -24,74M |
| EPS (Diluted) | -1,83 | -1,89 | -2,01 | -6,03 | -3,17 |
| Gross Profit | -263.000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -119,66M | -104,55M | -83,53M | -38,79M | -24,76M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 476,17M | 325,76M | 271,87M | 83,30M | 113,33M |
| Total Liabilities | 16,68M | 15,92M | 25,96M | 160,12M | 6,47M |
| Shareholders' Equity | 459,60M | 309,85M | 245,91M | -76,83M | 106,86M |
| Total Debt | 399.000,0 | 0,0 | 335.000,0 | 323.000,0 | 159.000,0 |
| Cash & Equivalents | 98,90M | 124,12M | 100,14M | 75,54M | 110,02M |
| Current Assets | 474,88M | 318,13M | 266,15M | 77,75M | 110,67M |
| Current Liabilities | 16,57M | 15,92M | 25,89M | 9,72M | 5,75M |